Salute e Benessere

ObsEva Recovers Full Worldwide Rights on Nolasiban

Ad hoc announcement pursuant to Art. 53 LR of the SIX Swiss Exchange Geneva, Switzerland – July13 , 2023 – ObsEva SA (SIX: OBSN), a biopharmaceutical company developing novel therapies for women's health, today announced that it has recovered full worldwide rights on nolasiban, a novel, oral oxytocin receptor antagonist being developed to improve clinical pregnancy and live birth rates in women undergoing embryo transfer after in vitro fertilization (“IVF”), following the...
Nasdaq GlobeNewswire
13/07/2023

Positive Phase III results for Roche's OCREVUS (ocrelizumab) twice a year…

Phase III OCARINA II trial met primary and secondary endpointsOCREVUS twice a year, 10-minute injection has the potential to further improve the treatment experience and expand OCREVUS usage in MS centres with IV capacity limitations or without IV infrastructureOCREVUS remains the first and only therapy approved for both RMS and PPMS, and more than 300,000 people have been treated globallyBasel, 13 July 2023 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase...
Nasdaq GlobeNewswire
13/07/2023

Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032…

Key Takeaways from the Liver Cirrhosis Market Report Discover which therapies are expected to grab the major liver cirrhosis market share @Liver Cirrhosis Market Report Liver Cirrhosis Overview Liver cirrhosis is a disease that causes a hardening of the organ. Nodules and abnormalities form on both the inside and outside of the liver, and these changes can be discovered with an ultrasonic examination or a CT scan. Because liver function steadily declines, liver...
PR Newswire
12/07/2023

Cellectis Appoints Dr. Cécile Chartier, Ph.D. to its Board of Directors

“We are very excited to welcome Dr. Chartier as a director of Cellectis' Board of Directors. Cécile's extensive experience in the development of next generation cell and gene therapies coupled with her deep knowledge of the U.S. biotechnology industry will be a huge asset to the Company,” said André Choulika, Ph.D., Chief Executive Officer at Cellectis. “We look forward to her contribution and insights as we continue advancing the development of our product candidates.”“I am honored to...
Nasdaq GlobeNewswire
12/07/2023

GENFIT: Half-Year Report of Liquidity Contract with Crédit Industriel et…

Lille (France), Cambridge (Massachusetts, United States), Zurich (Switzerland)July12 , 2023– GENFIT (Nasdaq and Euronext: GNFT), a late-stage biopharmaceutical company dedicated to improving the lives of patients with rare and severe liver diseases, today announced the half-year report of the liquidity contract with Crédit Industriel et Commercial. Under the liquidity contract GENFIT has with Crédit Industriel et Commercial, the following resources appeared on the...
Nasdaq GlobeNewswire
12/07/2023

Groupe Casino: Update on activity in France at 30 June 2023 and next steps in…

Update on activity in France at 30 June 2023and next steps in the conciliation process Paris, 12 July 2023As part of the conciliation procedure, the Casino group today announced its estimated second quarter 2023 French sales and its estimated first half 2023 French post-lease EBITDA.Sales (excluding VAT) LFL Change vs Y-1 1 Q2 22Q2 23e 2 Q2 23eQ1 23 Convenience 387 380+2 ...
Nasdaq GlobeNewswire
12/07/2023

Personalized Cancer Medicine Market to Reach $507.23 Billion, Globally, by 2032…

Request Sample Report on Personalized Cancer Medicine Market Analysis 2032. Allied Market Research- https://www.alliedmarketresearch.com/request-sample/13733 Request Sample Report on Personalized Cancer Medicine Market Analysis 2032. Allied Market Research-https://www.alliedmarketresearch.com/request-sample/13733 Prime determinants of growth Growing prevalence of cancer and technological advancement drive the growth of the global personalized cancer medicine market. However,...
PR Newswire
12/07/2023

Erectile Dysfunction Devices Market worth $2.7 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=195209494 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=195209494 Browse in-depth TOC on "Erectile Dysfunction Devices Market" 156 - Tables 35 - Figures 177 - Pages Erectile Dysfunction Devices Market Scope: The penile implants segment is expected to account for the largest share in 2022. The erectile dysfunction devices...
PR Newswire
12/07/2023

Skin Booster Market Will Touch USD 2,304 Million Value by 2030: P&S Intelligence

Get the sample pages of this report: https://www.psmarketresearch.com/market-analysis/skin-booster-market/report-sample Get the sample pages of this report:https://www.psmarketresearch.com/market-analysis/skin-booster-market/report-sample Rising Elderly Populace Boosts Demand for Skin Boosters Worldwide, the elderly populace is playing an important role in boosting the requirement for aesthetic treatments. The reduction of fibrous tissue and the loss of the network of glands and...
PR Newswire
12/07/2023

Stämm Announces the Appointment of Stefan Oschmann as Independent Director

Dr. Oschmann expressed his excitement about joining Stämm, stating, "Stämm's technology has the potential to revolutionize bioprocessing and create a major positive impact for the global biotech industry". Stämm is at the forefront of biomanufacturing technologies, harnessing the power of microfluidics and 3D printing to develop the first methodology for continuous industrial production of biologics and cell therapies. Dr. Oschmann expressed his excitement about joining Stämm, stating…
PR Newswire
12/07/2023

Controlled Freezing to -196°C: Single Use Support & SCHOTT Pharma Join Forces

SCHOTT Pharma AG & Co. KGaA and Single Use Support GmbH are joining forces to extensively test SCHOTT Pharma's innovative solutions for the safe and efficient handling of small volumes of pharmaceuticals at ultra-low temperatures. With substance handling temperatures as low as -196°C (-320°F), the aim of the collaboration is to create reliable solutions to ensure highest product quality. By joining forces and offering their combined knowledge and respective backgrounds to...
Nasdaq GlobeNewswire
12/07/2023

TUMI DEBUTS "ESSENTIALLY BEAUTIFUL" CAMPAIGN FOR FALL 2023, FEATURING RETURNING…

NEW YORK, July 12, 2023 /PRNewswire/ -- Today, international travel and lifestyle brand TUMI launched its Fall 2023 campaign, entitled "Essentially Beautiful." Aptly named, the two-part campaign will dig beneath the surface, showcasing the true beauty that lies in the details of TUMI's products through short videos featuring returning TUMI Crew members: Formula 1 driver Lando Norris, pro-footballer Son Heung-min and acclaimed singer-songwriter and actress Reneé Rapp. The campaign will…
PR Newswire
12/07/2023

New European Hypertension Guidelines Pave the Way for Greater Access to High…

Last month the European Society of Hypertension, or ESH, updated its treatment guidance to include RDN as a recommended treatment option for patients who need arterial hypertension management. Inclusion of RDN in the treatment guidelines means patients who struggle to lower their blood pressure through diet, exercise or antihypertensive medications will now have a safe, effective adjunctive treatment option. The guidelines were also endorsed by the European Renal Association (ERA) and the…
PR Newswire
12/07/2023

Cumulus Neuroscience Presents Key Data at the 2023 ENCALS Annual Meeting on…

"Detection of cognitive or behavioral changes in patients living with ALS or FTD can be challenging during clinical visits due to a variety of factors including fatigue and white coat syndrome," said Brian Murphy, PhD, Founder and Chief Scientific Officer of Cumulus. "We are encouraged by the analysis from our CNS-102 feasibility study, which confirms that patients living with these devastating conditions are willing and able to participate in home-based studies with intensive…
PR Newswire
12/07/2023

Recursion Announces Collaboration and $50 Million Investment from NVIDIA to…

Companies to collaborate on software for biotech and pharmaceutical companies to create improved patient treatments faster Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced a $50 million investment byNVIDIA, which was executed as a private investment in public equity (PIPE). Recursion also announced plans to accelerate development of its AI foundation models for biology and chemistry, which, in...
Nasdaq GlobeNewswire
12/07/2023

Caristo Diagnostics Piloting New Cardiac Disease Diagnostic Technology in UK NHS…

The new pilot supported by NHS England will involve five NHS trusts, including University Hospitals of Leicester NHS Trust, Liverpool Heart and Chest Hospitals NHS Foundation Trust, Milton Keynes University Hospital NHS Foundation Trust, Oxford University Hospitals NHS Foundation Trust, and Royal Wolverhampton NHS Trust. As part of the pilot, patients visiting Rapid Access Chest Pain Clinics (RACPCs) who undergo a CCTA scan as per NICE guidance, will have their scan analysed by the CaRi-Heart…
PR Newswire
12/07/2023

Raya Therapeutic announces early-stage R&D collaboration with argenx

"I cannot overstate the importance of the potential of combination studies for neurodegenerative diseases. Testing combinations of novel drugs is uncharted territory, and yet deeply needed for efficacious future therapies" said Dr. Leonard van den Berg, Director of the Netherlands ALS Center, Chairman of the European Network to Cure ALS (ENCALS), a network of the European ALS Centres and the Treatment Research Initiative to Cure ALS (TRICALS). "I cannot overstate the importance of…
PR Newswire
12/07/2023

Collagen and Gelatin Market worth $1.6 billion | MarketsandMarkets

Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95663122 Download an Illustrative overview:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95663122 Browse in-depth TOC on "Collagen and Gelatin Market" 227 - Tables 44 - Figures 241 - Pages Collagen and Gelatin Market Scope: The bovine segment accounted for the largest share of the source segment in the collagen and gelatin market in 2022. Based on Source, the...
PR Newswire
12/07/2023

Teleradiology Market to be Worth $6.28 Billion by 2030: Grand View Research…

Read 120-page market research report, "Teleradiology Market Size, Share & Trends Analysis Report By Product (Ultrasound, MRI, CT, X-ray), By Report (Preliminary, Final), By End-use (Hospital, Ambulatory Imaging Center, Radiology Clinics), By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 120-page market research report, " Teleradiology Market Size, Share & Trends Analysis Report By Product (Ultrasound, MRI, CT, X-ray), By Report…
PR Newswire
12/07/2023

Eitan Medical Launches Award Winning Infusion Management Platform Eitan…

Eitan Medical's infusion systems, Sapphire with its new universal plug and play cellular accessory Sapphire Connect and Avoset with the AvosetGo app, are now within reach, connecting and transmitting infusion treatment data to Eitan Insights. Eitan Medical's infusion systems, Sapphire with its new universal plug and play cellular accessory Sapphire Connect and Avoset with the AvosetGo app, are now within reach, connecting and transmitting infusion treatment data to Eitan Insights. Eitan...
PR Newswire
12/07/2023

Global Healthcare Accreditation's Standards 5.0 Awarded Coveted ISQua…

Established in 1985, ISQua is a member-based, not-for-profit community and organization dedicated to promoting quality improvement in health care. It is widely recognized as the "accreditor of accreditors" and the reference point for international healthcare accrediting bodies seeking an external validation of their standards. Its rigorous evaluation process ensures that accredited entities meet the highest international benchmarks, providing assurance to patients, insurers, ministries…
PR Newswire
12/07/2023

Medicilon Appoints Dr. Liu Jian as President of Drug Discovery Division

Dr. Liu Jian obtained his Ph.D. in Computational Chemistry and Organic Chemistry from the University of California, Los Angeles (UCLA), he subsequently conducted postdoctoral research at the University of California, Irvine, and the University of Pennsylvania. In 2018, Dr. Liu Jian served as the President of the Sino-American Pharmaceutical Professionals Association (SAPA) and is currently the Chairman of the board of directors of SAPA. In 2019, he was awarded the "Outstanding 50 Asian…
PR Newswire
12/07/2023

Healthcare Information Systems Industry Expected to Grow at CAGR of 13.3% from…

Order your copy of the Free Sample of "Healthcare Information Systems Industry Data Book - Hospital Information Systems, Pharmacy Automation Systems, Laboratory Informatics and Revenue Cycle Management Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 - 2030" Data Book, published by Grand View Research Order your copy of the Free Sample of"Healthcare Information Systems Industry Data Book - Hospital Information Systems, Pharmacy Automation Systems, Laboratory…
PR Newswire
12/07/2023

3D Cell Culture Market to Reach $3.31 Billion by 2030: Grand View Research, Inc.

Read 150-page market research report, "3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold Based, Scaffold Free), By Application (Cancer, Drug Development), By End-use, By Region, And Segment Forecasts, 2023 - 2030", published by Grand View Research. Read 150-page market research report, " 3D Cell Culture Market Size, Share & Trends Analysis Report By Technology (Scaffold Based, Scaffold Free), By Application (Cancer, Drug Development), By…
PR Newswire
12/07/2023
Altri  Comunicati